Skip to main content
. 2023 Feb 28;24(2):141–157. doi: 10.1089/sur.2022.393

Table 6.

Comparisons of Pre- and Post-Intervention Cohorts

 
Pre-intervention cohort
Post-intervention cohort
 
 
Value (n = 139)
%
Value (n = 126)
%
p
Demographics
Age (Mean ± SD) 33.1 ± 13.8   32.9 ± 13.1   0.883
Gender (male) 118 84.9 113 89.7 0.244
Race (African American) 99 71.2 87 69.0 0.699
Weight (kg) [mean ± SD] 80.1 ± 17.4   82.8 ± 20.0   0.244
Median income of home zip code: 
<50%
50%–100%
>100%

30
70
39

21.6
50.4
28.1

25
64
37

19.8
50.8
29.4

0.933
Transfer patient 35 25.2 28 22.2 0.572
Medical comorbidities
Any significant medical comorbidity 82 59.0 81 64.3 0.376
More than one medical comorbidity 35 25.2 35 27.8 0.632
Blood alcohol level >80 mg/dL 26 (n = 113) 23.0 29 (n = 112) 25.9 0.615
Urine drug screen positive for amphetamines, barbiturates, cocaine, or non-medicinal opioids 9 (n = 67) 13.4 14 (n = 59) 23.7 0.136
Prior abdominal surgery 18 12.9 20 15.9 0.498
Mechanism of injury
Penetrating injury 105 75.5 97 77.0 0.783
Mechanism of injury: 
Gunshot injury
Stabbing or other penetrating injury
Injury secondary to motor vehicle
Other blunt injury

72
33
28
6

51.8
23.7
20.1
4.3

77
20
24
5

61.1
15.9
19.0
4.0

0.447
Severity of injury
Overall ISS (median, IQR) 16 (9–25) (n = 137)   17 (9–26) (n = 123)   0.106
Abdominal abbreviated ISS (median, IQR) 3 (2–4) (n = 137)   3 (3–4) (n = 123)   0.293
Probability of survival (mean ± SD) 0.913 ± 0.203 (n = 135)   0.886 ± 0.249 (n = 120)   0.355
Initial lactate concentration (mmol/L) [mean ± SD] 4.7 ± 2.0 (n = 13)   4.8 ± 3.3 (n = 90)   0.901
Initial lactate concentration ≥2.2 mmol/L 12 (n = 13) 92.3 72 (n = 90) 80.0 0.453
Concomitant injuries
Any chest injury 53 38.1 53 42.1 0.514
Any pelvic fracture 26 18.7 32 25.4 0.188
Major spine or spinal cord injury (excluding spinous/transverse process fractures) 15 10.8 22 17.5 0.118
Fracture or major soft tissue extremity injury 36 25.9 39 31.0 0.362
Extra-abdominal vascular injury 5 3.6 11 8.7 0.080
Any significant extra-abdominal injury 93 66.9 96 76.2 0.095
Timing of laparotomy
Time in ED (min) [median, IQR] 36 (22-89) (n = 138)   44.5 (24-79)   0.593
Time from injury to operation (min) [median, IQR] 118 (68-231)   118.5 (77-217)   0.780
Laparotomy findings/details
Negative laparotomy (no abdominal injury encountered) 8 5.8 4 3.2 0.313
Non-therapeutic laparotomy (no abdominal injury treated during laparotomy) 13 9.4 14 11.1 0.637
Any gastrointestinal tract injury 66 47.5 70 55.6 0.189
Any colorectal injury 35 25.2 46 36.5 0.046
Number of units of PRBCs transfused (median, IQR) 0 (0–4)   0 (0–4)   0.947
Any preoperative or intraoperative PRBC Transfusion 68 48.9 61 48.4 0.934
Transfusion of ≥10 units of PRBCs (pre- operative and intra-operative) 13 9.4 16 12.7 0.384
Duration of laparotomy (min) [mean ± SD] 123.6 ± 57.6   133.5 ± 74.6   0.234
Concomitant extra-abdominal procedure 17 12.2 10 7.9 0.249
Abdominal fascia left open at end of initial laparotomy 29 20.9 29 23.0 0.672
Subsequent management
Postoperative ICU destination 77 55.4 77 61.1 0.346
Subsequent abdominal procedure 36 25.9 34 27.0 0.841
Subsequent extra-abdominal procedure 36 25.9 36 28.6 0.625
Days abdominal fascia left open (median, IQR) 3 (2–8) (n = 29)   2 (1–4) (n = 29)   0.214
Skin left open after final abdominal procedure 55 39.6 62 49.2 0.115
Postoperative use of vasopressors for >6 Hours 16 11.5 9 7.1 0.224
Follow-up
Days of follow-up (median, IQR) 45 (20 to >90)   58.5 (21 to >90)   0.446
Any contact made after hospital discharge 128 92.1 119 93.7 0.622
Contact made ≥30 d after laparotomy 100 71.9 93 73.8 0.733
Contact made ≥90 d after laparotomy 44 31.9 48 38.4 0.269
Patients whose only contact at ≥30 d was by telephone 7 (n = 11) 63.6 10 (n = 17) 58.8 0.799

SD = standard deviation; ISS = Injury Severity Score ; IQR = interquartile range; ED = emergency department; PRBCs = packed red blood cells; ICU = intensive care unit.